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http://dx.doi.org/10.1016/j.stemcr.2017.05.033SUMMARYNaivemouse embryonic stem cells (ESCs) can developmultiple fates, but the cellular andmolecular processes that enable lineage compe-
tence are poorly characterized. Here, we investigated progression from the ESC ground state in defined culture. We utilized downregula-
tion of Rex1::GFPd2 to track the loss of ESC identity. We found that cells that have newly downregulated this reporter have acquired
capacity for germline induction. They can also be efficiently specified for different somatic lineages, responding more rapidly than naive
cells to inductive cues. Inhibition of autocrine NODAL signaling did not alter kinetics of exit from the ESC state but compromised both
germline and somatic lineage specification. Transient inhibitionprior to loss of ESC identitywas sufficient for this effect. Genetic ablation
of Nodal reduced viability during early differentiation, consistent with defective lineage specification. These results suggest that NODAL
promotes acquisition of multi-lineage competence in cells departing naive pluripotency.INTRODUCTION
Pluripotency denotes a flexible cellular potential to
differentiate into all lineages of the developing embryo.
In mammals this property emerges in the epiblast of
the pre-implantation blastocyst (Boroviak et al., 2014;
Gardner, 1975; Rossant, 1975). After implantation,
epiblast cells remain pluripotent while undergoing pro-
found cellular and molecular changes in preparation for
gastrulation (Smith, 2017). In mice the post-implantation
epiblast develops into a cup-shaped epithelium, the egg
cylinder. Signaling cues from extra-embryonic tissues
then pattern the egg cylinder to establish anterior-poste-
rior and proximal-distal axes prior to lineage specification
(reviewed in Arnold and Robertson, 2009; Rossant and
Tam, 2009).
In mouse the naive phase of pluripotency can be
captured in culture in the form of embryonic stem cells
(ESCs) (reviewed by Nichols and Smith, 2012). Dual inhibi-
tion (2i) of MEK1/2 and glycogen synthase kinase 3 (GSK3)
(Ying et al., 2008), optionally in combination with the
cytokine leukemia inhibitory factor (LIF), allows mouse
ESCs to maintain the transcription profile, DNA hypome-
thylation status, and developmental potential character-
istic of the pre-implantation epiblast from which they are
derived (Boroviak et al., 2014, 2015; Habibi et al., 2013;
Leitch et al., 2013). ESCs in 2i are stable and relatively
homogeneous, a condition referred to as ‘‘ground state’’
(Marks et al., 2012; Wray et al., 2010). Such uniformity in
defined conditions provides an experimental system to
characterize cellular and molecular events that generate
multiple lineage-committed states from a developmental
blank canvas.This is an open access artiESC progression from the ground state is initiated simply
by removal of the inhibitors. In adherent culture this re-
sults predominantly in neural specification (Ying et al.,
2003) or in a mixture of neural andmesoendodermal fates,
depending on cell density (Kalkan et al., 2017). Previous
studies have identified expression of REX1 (gene name
Zfp42) as a marker of undifferentiated ESCs that is downre-
gulated prior to lineage specification (Betschinger et al.,
2013; Kalkan et al., 2017; Kalkan and Smith, 2014; Leeb
et al., 2014; Toyooka et al., 2008; Wray et al., 2010, 2011;
Yang et al., 2012). In this study, we exploit a Rex1::GFPd2
(RGd2) reporter cell line (Kalkan et al., 2017) to isolate cells
at initial stages of progression from naive pluripotency
following release from 2i in adherent serum-free culture.
We examine whether cells exiting the ESC state guided by
autocrine cues commit preferentially to a neural fate or
exhibit competence for multi-lineage differentiation.RESULTS
Multi-lineage Differentiation Capacity Is Manifest
after Loss of Naive ESC Identity
In Rex1::GFPd2 (RGd2) reporter ESCs, a short-half-life GFP
is expressed from the endogenous REX1 (Zfp42) locus
(Marks et al., 2012; Wray et al., 2011). Loss of the reporter
coincides with downregulation of naive pluripotency fac-
tors and functionally with extinction of clonal self-renewal
capacity (Kalkan et al., 2017) (Figures S1A–S1D). GFP
downregulation is asynchronous across the population.
For at least 16 hr cells remain uniformly GFP high, but by
24 hr expression is heterogeneous and in aminority of cells
the reporter has been downregulated (Kalkan et al., 2017).Stem Cell Reports j Vol. 9 j 1–15 j July 11, 2017 j ª 2017 The Authors. 1
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in 2i/LIF, whereas cells with high GFP produce undifferen-
tiated ESC colonies with the same efficiency as cells in the
initial 2i culture (Figure S1D, see also Kalkan et al., 2017).
We focused attention on the character of cells 24 hr after
2i withdrawal, the first time point at which it is practical
to isolate a substantial population of Rex1-low cells by
flow cytometry (Kalkan et al., 2017).
We first investigated capacity to form primordial germ
cell (PGC)-like cells (PGCLCs). Previous studies have
shown that undifferentiated ESCs are not directly compe-
tent for germline specification but must first transition to
a transient epiblast-like (EpiLC) population which can
then be induced to form PGCLCs (Hayashi et al., 2011; Na-
kaki et al., 2013). The EpiLC population is obtained by
transfer from 2i/LIF to N2B27 medium supplemented
with activin A, basic fibroblast growth factor (FGF), and
the serum substitute KSR (Knockout Serum Replacement)
for 48 hr (Hayashi et al., 2011). We assessed whether the
first cells that exit the ground state in N2B27 alone exhibit
competence to form PGCLCs. For this purpose we used
RGd2 ESCs transfected with a doxycycline (Dox)-regulat-
able expression construct containing the three germ-
line determination factors Prdm1 (BLIMP1), Prdm14, and
Tfap2c (Magnu´sdo´ttir et al., 2012; Nakaki et al., 2013). Sta-
ble transfectants were withdrawn from 2i for 24 hr and the
high and low GFP fractions isolated by fluorescence-acti-
vated cell sorting (FACS) (Figure 1A). Sorted cells (2,500)
were aggregated with or without Dox in non-adherent
96-well plates in medium containing 15% KSR (Nakaki
et al., 2013). After 4 days, the expression of OCT4 and
BLIMP1 protein was analyzed. Dual expression of BLIMP1
and OCT4 is a combination unique to PGCs and PGCLCs
(Hayashi et al., 2011; Kurimoto et al., 2008; Nakaki et al.,
2013). Furthermore, undifferentiated ESCs do not tolerate
appreciable levels of BLIMP1 protein (Magnu´sdo´ttir et al.,
2013). In the absence of Dox, few cells co-expressing
BLIMP1 with OCT4 were present in aggregates from either
population (Figure 1B). Dox treatment induced double-
positive cells from the Rex1-low fraction but had little
effect on the Rex1-high cells (Figures 1B and 1C). Quantita-
tive imaging analysis confirmed a higher number of cells
were double-positive for OCT4 and BLIMP1 in cultures
derived from Rex1-low cells (Figure 1D), at a frequency
comparable with that previously reported for EpiLCs (Na-
kaki et al., 2013). By qRT-PCR analysis we detected upregu-
lated expression of endogenous Prdm1 (BLIMP1), along
with Prdm14, Tfap2c, Nanos3, and Stella, as well as mainte-
nance of Pou5f1 (OCT4) (Figure 1E). T (BRACHYURY) was
induced transiently on day 2 as previously described
for PGCLC induction (Figure 1E) (Nakaki et al., 2013).
We also carried out cytokine induction of PGCLCs and
observed earlier upregulation of PGC markers Nanos3,2 Stem Cell Reports j Vol. 9 j 1–15 j July 11, 2017Tfap2c, and Stella in Rex1-low cells compared with Rex1-
high cells (Figure S1E). The kinetics of upregulation and
overall expression levels of PGC markers were comparable
with those for EpiLC treated in parallel (Figure S1E).
Thus, ESCs newly exited from the ground state under auto-
crine stimulation in defined conditions have acquired
competence for germline specification.
We then examined somatic lineage potential of Rex1-low
cells. Sorted fractionswere plated inmedia that favormeso-
derm, definitive endoderm, or neural lineages, respectively,
and the timing and efficiency of differentiation quantified.
Activin A combined with GSK3 inhibition (GSK3(i))
elicits the upregulation of primitive-streak markers
such as BRACHYURY (T) in differentiating ESCs (Gadue
et al., 2006; Morrison et al., 2015; Tsakiridis et al., 2014;
Turner et al., 2014). We modified RGd2 cells to express an
mKO2 fluorescent reporter from the T locus (Figure 2A).
T::mKO2 was not expressed in undifferentiated ESCs in 2i
(Figure S2A), and not detected until day 3 of treatment
with activin A plus GSK3(i). In contrast, Rex1-low cells
replated in the presence of activin A and GSK3(i) upregu-
lated T::mKO2 after 1 day and all cells were positive by
day 2. Rex1-high cells upregulated T::mKO2 more slowly
and some cells remained GFP high even after 3 days, indi-
cating they remained undifferentiated and unresponsive
to differentiation cues (Figure 2B).
To test further differentiation, we plated the sorted frac-
tions in conditions that promote lateral mesoderm (Nishi-
kawa et al., 1998; Yamashita et al., 2000). All populations
gave rise to FLK1-positive/E-CADHERIN-negative cells after
4–5 days (Figure 2C).
Weassesseddefinitiveendodermdifferentiationafter sort-
ing by measuring the percentage of CXCR4/E-CADHERIN
double-positive cells (Morrison et al., 2008; Yasunaga
et al., 2005) under specific inductive conditions (Morrison
et al., 2015) (Figure 2D). Compared with 2i cells or the
Rex1-high population, fewer double-positive cells accumu-
lated fromtheRex1-lowcells (Figure2E).However,wenoted
that the majority of Rex1-low cells died after replating in
these conditions (Figure 2F). The survivors formed SOX17/
FOXA2 double-positive cells, and every SOX17-positive
cell was positive for FOXA2, substantiating endoderm
identity (Burtscher and Lickert, 2009) (Figures S2B and
S2C). Induction of the later marker, SOX17, was reduced
from Rex1-low cells compared with Rex1-high or 2i cells.
We hypothesized that sorted Rex1-low cells might have
impaired survival and differentiation because of a require-
ment for high cell density in the endoderm program. We
therefore combined sorted cells with unsorted populations
to reproduce the density of non-manipulated cultures (Fig-
ure 2G). To trace the sorted cell progeny, we employed
RGd2 cells constitutively labeledwithmKO2under the con-
trol of a CAG promoter (Niwa et al., 1991). Two hundred
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A
B C
RGd2
Blimp1/Prdm14
/Tfap2c-inducible
2i
24hrs
N2B27 Rex1-high
Rex1-low
15% KSR
+/-Dox
Immunostaining, 
RT-qPCR
DAPI
BLIMP1
OCT4
DAPI
BLIMP1 
OCT4
Rex1-lowRex1-high
Day 4
+Dox
E
Rex1-high
 +Dox
Rex1-low
 +Dox
2i
T (Bra)
R
el
at
iv
e 
ex
pr
es
sio
n
Prdm1 UTR
(Blimp1)
Prdm14 
UTR
Tfap2c
UTR Nanos3 Stella
Pou5f1 
(Oct4)
DAPI
BLIMP1
OCT4
Rex1-high
- Dox
Rex1-low Rex1-high Rex1-low
+ Dox
60μm
D
 + Dox Rex1-low
 + Dox Rex1-high
0
20
40
60
80
100
BL
IM
P1
OC
T4
OC
T4
/BL
IM
P1
%
 o
f p
os
itiv
e 
ce
lls
**
*
**
** ** ** ** **
**
*
0
0.2
0.4
0.6
0.8
1.0
1.2
d0 d2 d4
0
0.2
0.4
0.6
0.8
1.0
1.2
d0 d2 d4
0
0.2
0.4
0.6
0.8
1.0
1.2
d0 d2 d4
0
0.2
0.4
0.6
0.8
1.0
1.2
d0 d2 d4
0
0.2
0.4
0.6
0.8
1.0
1.2
d0 d2 d4
0
0.2
0.4
0.6
0.8
1.0
1.2
d0 d2 d4
0
0.2
0.4
0.6
0.8
1.0
1.2
d0 d2 d4
*
*
*
*
20μm
*
*
Figure 1. Acquisition of PGCLC Differentiation Capacity
(A) Experimental setup for transcription factor-dependent PGCLC specification.
(B) Expression of BLIMP1 and OCT4 in day-4 aggregates differentiated in the presence or absence of Dox to induce transcription factor
overexpression. Scale bar, 60 mm.
(C) Zoom-in of the expression of BLIMP1 and OCT4 in day-4 aggregates differentiated in the presence or absence of Dox to induce
transcription factor overexpression. Asterisks indicate overexpression staining artifacts. Scale bar, 20 mm.
(D) Quantification of the percentage of cells expressing BLIMP1, OCT4, and both markers in aggregates cultured with Dox and stained on
day 4.
(E) qRT-PCR of endogenous PGC-associated transcripts.
Data in (D) and (E) from three independent experiments, mean and SD shown. *p < 0.01, **p < 0.001. See also Figure S1.
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parental cells per 3.8 cm2 dish. Cells were exposed to defin-
itive endoderm differentiation medium, then fixed andstained for SOX17 at day 4 (Figure S2D). The total number
of mKO2-positive clones was determined, along with the
number of SOX17-positive cells per clone and the cloneStem Cell Reports j Vol. 9 j 1–15 j July 11, 2017 3
K0
20
40
60
80
100
24hrs
unsorted
cells
1 2 3 4P
er
ce
nt
ag
e 
of
 S
O
X1
+ 
 c
el
ls
**
**
*
Days after sort
2i 
24h Rex1-high
24h Rex1-low
Neural
RGd2
2i
24hrs
N2B27 Rex1-high
Rex1-low
N2B27, Laminin
SOX1 immunostaining
+d4+d3+d2+d1
A
RGd2
T::mKO2
cells
24hrs
N2B27 Rex1-high
Rex1-low
ActivinA/Gsk3(i)
Flow cytometry
+d3+d2+d1
ActivinA/Gsk3(i)
Lateral MesodermC
D
RGd2
2i
24hrs
N2B27 Rex1-high
Rex1-low
10% FCS
Collagen IV
FLK1/E-CADHERIN staining
Flow cytometry
d5d4d3d2d1
Clonal definitive endoderm
Definitive endoderm
RGd2
2i
24hrs
N2B27 Rex1-high
Rex1-low
N2B27 base, 
GSK3(i), ActivinA,
FGF4, Heparin
PI103
SF5 base (-vit.A)
GSK3(i), ActivinA
FGF4, Heparin
PI103, EGF
CXCR4/E-CADHERIN staining, 
Flow cytometry
d5d4d3d2d1
G
H JI
2i
Rex1-high
Rex1-low
24hrs
24hrs
Single cell-derived 
clones
Definitive 
endoderm 
differentiation
RGd2
mKO2+
labelled 
cells
Unlabelled
RGd2
cells
0
20
40
60
80
100
Re
x1
-hi
gh
Re
x1
-lo
w
N
um
be
r o
f c
lo
ne
s 
0-2
5
25
-50
50
-75
75
-10
0
Fr
eq
ue
nc
y
Percentage of SOX17 + cells per clone
Fr
eq
ue
nc
y
Number of cells per clone
0 
10 
20 
30 
40 
%
 F
LK
1+
/E
-
CA
DH
- c
e
lls
 
ND ND
24hrs
unsorted
cells
1 2 3 4 5
Day after sort
2i 
24h Rex1-high
24h Rex1-low
24h Rex1-high
24h Rex1-low
24h Rex1-high
24h Rex1-low
F
0
20
40
60
80
100
120
N
um
be
r o
f c
el
ls 
(%
)
**
*
* *
**
**
1 2 3 4 5
Day after sort
2i 
24h Rex1-high
24h Rex1-low
E
0
20
40
60
80
%
 C
XC
R4
+/
E-
CA
DH
+ 
ce
lls
*
*
*
* *
*
24hrs
unsorted
cells
1 2 3 4 5
Day after sort
2i 
24h Rex1-high
24h Rex1-low
Day after sort
%
R
G
d2
+
 
ce
lls
 
24hrs
unsorted
cells
2i 
24h Rex1-high
24h Rex1-low
0
20
40
60
80
100
120
1 2 3
B
Day after sort
%
 T
::m
KO
2+
 ce
lls
 
24hrs
unsorted
cells
2i 
24h Rex1-high
24h Rex1-low
0
20
40
60
80
100
120
1 2 3
*
*
*
*
0
0.1
0.2
0.3
0.4
0.5
0.6
0
0.3
0.6
0.9
1-5
0
50
-90
90
-13
0
13
0-1
70
17
0+
(legend on next page)
4 Stem Cell Reports j Vol. 9 j 1–15 j July 11, 2017
Please cite this article in press as: Mulas et al., NODAL Secures Pluripotency upon Embryonic Stem Cell Progression from the Ground State,
Stem Cell Reports (2017), http://dx.doi.org/10.1016/j.stemcr.2017.05.033
Please cite this article in press as: Mulas et al., NODAL Secures Pluripotency upon Embryonic Stem Cell Progression from the Ground State,
Stem Cell Reports (2017), http://dx.doi.org/10.1016/j.stemcr.2017.05.033sizes. Similar numbers of clones and sizes were obtained
from Rex1-high and -low cells (Figures 2H and 2I). The ma-
jority of Rex1-low cells were able to produce colonies con-
taining SOX17-positive cells, although the output was less
than from Rex1-high clones (Figure 2J).
Finally, we examined cell fate acquisition in N2B27
alone, which is permissive for neural differentiation (Ying
et al., 2003). The great majority (R80%) of cells from
both Rex1 fractions became immunopositive for SOX1,
an exclusive marker of neuroectoderm (Pevny et al.,
1998; Zhang et al., 2010) (Figure 2K). However, Rex1-low
cells showed early upregulation of SOX1, with most cells
becoming SOX1 positive on day 2, a day before the Rex1-
high population (Figures 2K and S2E). In these conditions,
cell viability and expansion were not significantly different
between the populations (Figure S2F). Rex1-low cells subse-
quently also showed accelerated onset of expression of the
neuronal marker type III b-TUBULIN (Lee et al., 1990)
(Figure S2G).
Overall, these data indicate that after 24 hr of monolayer
culture guided by autocrine cues, Rex1-low cells are compe-
tent for multi-lineage specification and respond more
rapidly to induction than either ground-state ESCs or
Rex1-high cells.
NODAL Does Not Regulate Kinetics of Exit from the
Naive State
FGF4 is an autocrine factor that drives ESC transition via
ERK signaling upon release from 2i (Betschinger et al.,
2013; Kunath et al., 2007; Leeb et al., 2014; Stavridis
et al., 2007). A second potential autocrine regulator
is NODAL (Fiorenzano et al., 2016; Mullen et al., 2011;
Ogawa et al., 2007). Detection of SMAD2 phosphorylation
indicates that the pathway is active in ground-state
ESCs, attributable to autocrine expression of NODAL (Fig-
ure S3A). Treatment with the ALK5/4/7 receptor inhibitorFigure 2. Multi-lineage Differentiation Capacity Is Manifest in R
(A and B) Experimental set up and sample analysis for activin A +
expressing T:mKO2 or RGd2 (B).
(C) Experimental setup and sample analysis for lateral mesoderm
E-CAD cells.
(D) Experimental setup and sample analysis for definitive endoderm d
(E) Percentage of CXCR4+/E-CADH+ double-positive cells.
(F) Normalized number of cells during definitive endoderm differen
obtained in that individual experiment.
(G) Single-cell analysis during definitive endoderm differentiation by
density among unlabeled cells.
(H) Number of clones after 4 days of differentiation.
(I) Distribution of the number of cells per clone.
(J) Distribution of the percentage of SOX17-positive cells per clone.
(K) Experimental setup and sample analysis for neural differentiation.
during the differentiation time course.
Data from three independent experiments, mean and SD shown. *p <A83-01 (Alk(i)) (Tojo et al., 2005) eliminated SMAD2 phos-
phorylation after 30 min (Figure S3A). However, Alk(i) did
not affect colony-forming capacity in 2i/LIF, even after
continuous culture for three passages (Figure S3B), con-
firming that the NODAL pathway is not needed formainte-
nance of ground-state mouse ESCs.
We examined the contribution of autocrine NODAL
pathway signaling in progression from the ESC state. We
analyzed changes in gene expression in cells withdrawn
from 2i in the continuous presence of Alk(i) (Figure 3A)
and found no difference in the dynamics of downregula-
tion of Nanog or Klf2 mRNA (Figure 3B), nor of NANOG
and KLF4 protein (Figures 3C and S3C). Functionally, the
rate of decay in ESC clonogenicity was also unaffected
(Figure 3D).
We evaluated expression of genes associated with the
early post-implantation epiblast. Initial upregulation of
Fgf5 and Otx2 was marginally reduced when NODAL
signaling was inhibited (Figure 3E). However, these genes
were subsequently downregulated more acutely on days 3
and 4 (Figure 3E). Conversely, transcripts for neuroecto-
dermal lineage factors Sox1, Zic1, and Pou3f3 were strongly
upregulated in day-3/-4 Alk(i)-treated cultures, before
appreciable expression in vehicle-treated cells (Figure 3F).
At the protein level, most cells in Alk(i)-treated cultures
had downregulated OCT4 and were SOX1 positive after
3 days, indicative of neural commitment, whereas control
cultures at this time point displayed a mosaic pattern of
co-exclusive SOX1 and OCT4 immunostaining (Lowell
et al., 2006) (Figure 3G).
To validate findings with the inhibitor, we deployed
small interfering RNAs (siRNAs) against NODAL signaling
pathway components. In Nodal, Smad2/3, and Tdgf1
knockdown experiments, the emergence of OCT4/
SOX2+ and SOX2+/SOX1+ cells was accelerated (Figures
S3D and S3E). We conclude that suppression of NODALex1-Low Cells
GSK3(i) treatment (A). Histogram shows the percentages of cells
differentiation. Histogram showing the percentage of FLK1+/
ifferentiation.
tiation. The number of cells was normalized to the highest value
seeding fluorescently labeled Rex1-Pos or Rex1-Neg cells at clonal
Histogram on the right shows the percentage of SOX1-positive cells
0.05, **p < 0.01. See also Figure S2.
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naive state but promotes subsequent specification to the
neural lineage.
NODAL Signaling Potentiates Multi-lineage
Differentiation
Interrogation of RNA-sequencing data from RGd2 sorted
cells (Kalkan et al., 2017) revealed that NODAL pathway
ligands, receptors, intracellular mediators, and target
genes are expressed in undifferentiated ESCs and in 24-hr
Rex1-high cells. Rex1-low cells, on the other hand, display
reduced levels of Nodal and Gdf3 transcripts and decreases
in expression of the convertase Pcsk6 (Pace4), as well as of
pathway targets Lefty1, Lefty2, and Smad6 (Figure S4A).
This prompted treatment with Alk(i) only after sorting (Fig-
ure 4). We found that the Rex1-high population still re-
sponded by accelerated upregulation of SOX1 but the
Rex1-low fraction showed no change, consistent with the
pathway already being downregulated. These observations
may explain why exogenous activin A is required to drive
mesoendodermal lineage specification.
In light of these results, we postulated that NODAL
signaling may function during the primary transition
from naive pluripotency. We therefore inhibited the
pathway for only the first 24 hr and analyzed the resulting
Rex1-low cells. In line with results for continuous treat-
ment, exposure to Alk(i) for 24 hr had little effect on down-
regulation of RGd2 (Figure S4B) or other naive pluripo-
tency factor transcripts (Figure S4C). Upregulation of
early post-implantation markers was also similar to that
in vehicle-treated cells (Figure S4C). One day after sorting
and replating, SOX1 protein was detectable only in a mi-
nority of untreated cells (Figure 5A). In contrast, up to
half of cells generated after Alk(i) treatment upregulated
SOX1 protein on day 1. Cell numbers appeared reduced
at all time points for inhibitor-treated samples, although
the difference was not statistically significant (Figure 5B).
We examined whether faster neural specification as a
consequence of Alk(i) pre-treatment has consequences for
other lineages. We analyzed the response of Alk(i)-treatedFigure 3. Inhibition of Endogenous NODAL Signaling Does Not Af
(A) Experimental setup.
(B) Relative expression of pluripotency factors Klf2 and Nanog over t
(C) Percentage of KLF4- and NANOG-positive cells over time after 2i w
of Alk(i).
(D) Self-renewal capacity declines at a comparable rate for cells treat
(E) Relative expression of post-implantation markers Fgf5 and Otx2 s
controls.
(F) Relative expression of neural-associated genes Sox1, Zic1 and Pou
(G) Inhibition of NODAL signaling results in accelerated reduction of O
Scale bar, 50 mm.
Data from three independent experiments, mean and SD shown. *p <cells to activin A/GSK3(i). Rex1-low cells showed a major
reduction in the number of T::mKO2-positive cells (Fig-
ure 5C). Interestingly, this was mainly attributable to
reduced total cell numbers after exposure to activin A/
GSK3(i) (Figures 5D and S4D). A similar reduction in cell
survival/proliferation was observed in cells exposed to
lateral mesoderm differentiation conditions (Figures S4E–
S4G). Thus, Rex1-low cells emerging after Alk(i) treatment
appear to be compromised in their ability to respond
to mesoderm-inducing signals. To evaluate endodermal
specification, we employed the clonal mixing protocol
described previously (Figure 5E). The total number of
clones was not reduced (Figure S4H), but we observed a
shift to smaller clones (Figure 5F) with fewer SOX17-posi-
tive cells (Figure 5G).
We assessed whether prior treatment with Alk(i) for 24 hr
affected the potential of Rex1-low cells to respond to PGC-
inducing transcription factors (Figure 5H). Alk(i)-treated
cells produced less compact and smaller aggregates than
control cultures (Figure 5H). The gene expression profile
at days 2 and 4 of culture showed lower upregulation
of endogenous Prdm14, Nanos3, and Stella, indicating
significantly impaired PGCLC induction (Figure 5I). We
similarly observed lower upregulation of endogenous
Nanos3, Tfap2c, and Stella upon cytokine induction of
PGCLCs (Figure S4I).
Collectively these findings indicate that suppression of
NODAL signaling during exit from the ESC state reduces
the capacity of cells to respond productively to inductive
cues for mesoderm, endoderm, and germ cell specification.
Nodal Gene Deletion Compromises Germline and
Somatic Lineage Specification
To confirm that the effect of Alk inhibitor treatment was
indeed attributable to the absence of NODAL stimulation,
we genetically inactivated Nodal. We employed CRISPR/
Cas9 and used a pair of guide RNAs targeting the second
and third exons (Figure S5A). Two clones negative forNodal
mRNA were identified and used for subsequent analyses
(Figure S5B). Consistent with the inhibitor experiments,fect Exit from the Naive State
ime when cells are differentiated in control (DMSO) or Alk(i).
ithdrawal when cells are differentiated in the presence or absence
ed with vehicle control or Alk(i).
hows faster earlier downregulated for cells treated with Alk(i) over
3f3 over time when cells are differentiated in controls or Alk(i).
CT4 protein and increase in SOX1 protein at day 3 of differentiation.
0.01. See also Figure S3.
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Figure 4. NODAL Signaling Acts during
the Transition from the Naive State
Inhibition of Nodal signaling with Alki(i) in
Rex1-high and Rex1-low sorted fractions.
Graphs show percentages of SOX1-positive
cells after sorting and replating in the
presence or absence of Alk(i). Data from
three independent experiments, mean and
SD shown. *p < 0.05.
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Nodal-deficient ESCs in 2i/LIF (Figure 6A). The expression
of key pluripotency or early post-implantation genes was
also unaffected (Figure 6B). Expression of Lefty1, a NODAL
target gene, was reduced to almost undetectable levels in
the knockout clones but could be restored by addition of
activin A to the culture medium (Figure 6B).
We examined the lineage propensity of 24-hr Rex1-low
cells from Nodal-mutant cells. During cytokine induction
of PGCLCs, mutant aggregates were less compact (Fig-
ure 6C) and the expression of PGC markers was signifi-
cantly reduced. Nodal KO cells also displayed a marked
reduction in generation of both SOX1- and BRACHYURY-
positive cells in respective inductive culture conditions
(Figures 6E and 6F). In either condition, fewer mutant
cells survived compared with wild-type controls or activin
A-treated mutant cells. The expression of Gdf3 (Figure 6B),
a Vg-1 homolog that may elicit Nodal-like responses (Chen
et al., 2006), might partly compensate for the absence of
NODAL to enable residual lineage specification. Nonethe-
less, our results indicate that autocrine NODAL signaling
during transition from naive pluripotency facilitates acqui-
sition of multi-lineage competence.DISCUSSION
The defined context of ground-state ESC culture provides
opportunities for experimentally dissecting the interplay
between intrinsic and extrinsic factors that mediate pro-
gression through pluripotency. Here we investigated the
trajectory of ESCs released from the ground state withmin-
imal extrinsic input. We isolated cells that have lost ESC8 Stem Cell Reports j Vol. 9 j 1–15 j July 11, 2017identity within 24 hr based on downregulation of RGd2,
corroborated functionally by extinction of self-renewal
capability (Kalkan et al., 2017). These cells show gene
expression features related to the peri-implantation
epiblast (Kalkan et al., 2017). Capacitation for germline
and somatic lineage specification may be acquired around
this formative period (Hayashi et al., 2011; Smith, 2017).
Indeed newly formed Rex1-low cells readily differentiated
into the germline and somatic lineages. Furthermore, we
found that endogenous NODAL signaling is crucial for
robust multi-lineage competence of cells transitioning
out of naive pluripotency.
Rex1-low cells show more rapid upregulation of lineage
markers in response to inductive stimuli compared with
ground-state ESCs or Rex1-high cells. They have also
gained capacity for PGCLC induction. It has previously
been established that responsiveness to germ cell induc-
tion cues or factors is not manifest in naive ESCs or the
pre-implantation epiblast but is a property acquired during
developmental progression (Hayashi et al., 2011; Nakaki
et al., 2013). By transcription factor overexpression, very
few BLIMP1/OCT4 double-positive cells could be obtained
from the Rex1-high fraction, while the Rex1-low fraction
generated them readily. Presumably, mis-expression of
germ cell-determining transcription factors interferes
with transition of undifferentiated ESCs or 24-hr Rex1-
high cells to competence. For cytokine induction of
PGCLCs, however, Rex1-high cells are evidently able to
transition to a competent state. Slower upregulation of
PGCLC markers in Rex1-high cells compared with Rex1-
low cells is consistent with this explanation. Thus in the
defined ESC system, capacity for PGCLC induction appears
to be gained rather rapidly upon loss of Rex1.
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Figure 5. NODAL Signaling during Exit from the Naive State Prevents Precocious Neuralization
(A) Percentage of SOX1-positive cells arising from Rex1-low cells following control or Alk(i) treatment.
(B) Number of cells over the period analyzed in (A).
(C) Activin A/GSK3(i) induction of Alk(i) or control treated Rex1-low cells. Numbers of T::mKO2-positive cells, along with total cell
numbers.
(legend continued on next page)
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Expression can be detected in the inner cell mass and
persists throughout the epiblast until axis specification,
when it becomes restricted to the proximal posterior region
(Conlon et al., 1994; Mesnard et al., 2006). NODAL activity
relies on pro-protein convertases, FURIN and PACE4, pro-
duced by the extra-embryonic ectoderm, which cleave
and activate pro-NODAL (Beck et al., 2002; Mesnard et al.,
2011). Nodal-deficient embryos die by embryonic day 7.5
(Conlon et al., 1994, 1991; Zhou et al., 1993). NODAL
activity and autoinduction in the early post-implantation
epiblast appears necessary to sustain pluripotency (Guz-
man-Ayala et al., 2004; Mesnard et al., 2006) and is depen-
dent on paracrine provision of convertases by the extra-em-
bryonic tissues (Beck et al., 2002). Mutant embryos show
precocious upregulation of neural markers throughout the
egg cylinder and fail to form a primitive streak (Brennan
et al., 2001; Camus et al., 2006; Lu and Robertson, 2004).
Nodalmutants also fail to specify the anterior visceral endo-
derm (Brennan et al., 2001), a signaling center essential for
the establishment of anterior-posterior polarity. The multi-
ple functions of NODAL, the complex interplay between
extra-embryonic tissues and the epiblast, and the potential
redundant activityofGDF3 (Chenet al., 2006)have compli-
cated theprecise delineationof its roles inpluripotencypro-
gression and lineage specification (Robertson, 2014).
Mouse ESCs express NODAL and exhibit phosphorylated
SMAD2/3 (Mullen et al., 2011; Ogawa et al., 2004). Inhibi-
tion of NODAL signaling enhances SOX1 expression during
differentiation (Matulka et al., 2013; Turner et al., 2014).Our
results show that inhibition of NODAL signaling does not
affect the acute downregulation of pluripotency factors
whenground-stateESCsare released from2i, in linewithpre-
vious observations (Turner et al., 2014). Upregulation of
earlypost-implantationmarkers is alsounaffected.However,
suppression of NODAL signaling compromises subsequent
responses to inductive stimuli formesoderm and endoderm,
and results in precocious upregulation of neural markers.
Interestingly, Nodal knockout ESCs exhibited a slightly
different phenotype from inhibitor-treated cells. Mutant
cells that exited the naive state showed reduced induction
of both BRACHYURYand SOX1, with poor survival in both
conditions. Lineage specification was not completely abol-(D) To determine the normalized number of cells as a percentage for e
the highest value obtained in that independent experiment.
(E) Experimental setup of definitive endoderm clonal assay.
(F) Distribution of the percentage of SOX17-positive cells per clone.
(G) Distribution of the number of cells per clone.
(H) Experimental setup of transcription factor-dependent PGCLC diffe
Alk(i)-treated and control cells. Scale bar, 1 mm.
(I) qRT-PCR assay of PGC-associated genes during induction process.
Data from three independent experiments, mean and SD shown. *p <
10 Stem Cell Reports j Vol. 9 j 1–15 j July 11, 2017ished, however, either because the requirement for NODAL
pathway stimulation is not absolute, or possibly due to
compensatory activity of GDF3. Both Alk(i)-treated and
Nodal-mutant cells showed reduced induction of PCGLCs
in response to either transcription factors or cytokines.
A key finding in this study is that the requirement for
NODAL signaling is not restricted to the lineage priming
stage but is apparent during initial transition from the
ESC state, while cells are in the reversible Rex1-high condi-
tion (Kalkan et al., 2017; Martello and Smith, 2014). We
have proposed that ESCs and naive epiblast cells transit
through a formative phase of pluripotency during which
they acquire competence for multi-lineage differentiation,
including germline determination, prior to lineage priming
(Kalkan and Smith, 2014; Smith, 2017). Formative cells are
expected to respond to inductive signals rapidly and effi-
ciently, as observed for Rex1-low cells at 24 hr. The molec-
ular process of lineage capacitation remains unclear but is
associated with reconfiguration of the transcription factor
network,metabolic reprogramming, enhancer remodeling,
and widespread epigenome and chromatin modification
(Buecker et al., 2014; Choi et al., 2016; Dunn et al., 2014;
Fiorenzano et al., 2016; Kalkan et al., 2017; Zylicz et al.,
2015). Our findings point to a pivotal role for NODAL
signaling in establishing formative pluripotency, in keep-
ing with observations of a requirement for continuous
NODAL activity to sustain pluripotency in the early post-
implantation epiblast (Mesnard et al., 2006). Interestingly,
SMAD2/3 is reported to be recruited by ‘‘master tran-
scription factors’’ to regulatory loci in a cell type-specific
manner (Mullen et al., 2011). In addition, a recent study
in human ESCs suggested that SMAD2/3 is able to recruit
histone methyltransferases to gene promoters (Bertero
et al., 2015). Therefore, multi-lineage capacitation could
depend upon the presence of SMAD2/3 at specific loci in
ESCs during the transition from naive pluripotency.EXPERIMENTAL PROCEDURES
Mouse ESC Culture and Differentiation
RGd2 ESCswere derived in 2i/LIF fromheterozygous embryos (Kal-
kan et al., 2017). The RGd2/T:mKO2 cell line was generated by tar-
geting the endogenous T (BRACHYURY) locus with T2A-mKO2.ach independent experiment, we normalized the number of cells by
rentiation. Images show day-4 cultures in the presence of Dox from
0.05, **p < 0.01, ***p < 0.001. See also Figure S4.
A B
C D
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F
G
Figure 6. Deletion of Nodal Impairs Germline and Somatic Lineage Competence
(A) Colony-forming assay on wild-type (WT) and Nodal-mutant (KO) ESCs in 2i/LIF.
(B) Heatmap of marker expression determined by qRT-PCR in Nodal KO cells in 2i and in the presence of 5 ng/mL activin A. n.d., not
detected.
(legend continued on next page)
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catalog no. 1890) in N2B27 medium (Stem Cells, SCS-SF-NB-02)
supplemented with 1 mM PD0325901 and 3 mM Chir99021 (2i)
without LIF, and passaged with Accutase (Millipore, SF006) every
2–3 days. For sorting experiments, cells were plated for 24 hr in
2i at 1.53 104 cells/cm2 before washing once with PBS and chang-
ing themedium to N2B27. After 24–26 hr, cells were sorted by flow
cytometry according to GFP levels into Rex1-high (highest 15%)
and Rex1-low (lowest 15%) populations using a MoFlo sorter
(Beckman Coulter). For neural differentiation, cells were plated at
1.0 3 104 cells/cm2 on laminin-coated dishes (Sigma-Aldrich,
L2020) in N2B27.Mediumwas changed every other day. For defin-
itive endoderm induction (Morrison et al., 2015), 1.5 3 104 cells/
cm2 were plated in gelatin-coated plates directly in DE1, before
switching to DE2 on day 2. DE2 was renewed on days 4 and 5.
DE1 comprises batch-tested N2B27, supplemented with 3 mM
Chir99021, 20 ng/mL activin A, 10 ng/mL recombinant mouse
FGF4 (R&D Systems, 235-F4-025), 1 mg/mL heparin (Sigma-
Aldrich, H3393), and 100 nM PI103 (Cayman Chemical,
10009209). DE2 medium is composed of SF5 base (DMEM/F12
[Life Technologies, 21331-020], 0.25% N2, 1% B27 without RA
[Life Technologies, 12587-010], 0.05% BSA [Life Technologies,
15260-037], 0.1 mM b-mercaptoethanol [Life Technologies,
31350-010], 2 mM L-glutamine [Life Technologies, 25030-081]),
supplemented with 3 mM Chir99021, 20 ng/mL activin A,
10 ng/mL FGF4, 1 mg/mL heparin, 100 nM PI103, and 20 ng/mL
epidermal growth factor (EGF; Preprotech, AF-100-15). Lateral
mesoderm differentiation (Nishikawa et al., 1998) was performed
by plating 1.2 3 104 cells/cm2 cells in collagen-coated plates (BD
BioCoat, 354591) in Glasgow’s minimum essential medium
(GMEM; Sigma-Aldrich, G5154) with 10% batch-tested fetal calf
serum (Sigma-Aldrich), 13 non-essential amino acids (NEAA; Life
Technologies, 11140-050), 1 mM sodium pyruvate (Life Technolo-
gies, 11360-070), and 1 mM L-glutamine.
Activin A (20 ng/mL) and Chir99021 (3 mM) (GSK3(i)) treatment
of sorted fractions was carried out on fibronectin-coated plates
(Millipore, FC010) at 1.53 104 cells/cm2. NODAL inhibitor exper-
iments were carried out using A83-01 1 mM (Alk(i), Tocris Biosci-
ence, 2939) with DMSO (1:10,000) as a carrier control.
Colony-forming assays were conducted by plating 100 cells/cm2
per well in laminin-coated plates in 2i supplemented with
1,000 U/mL LIF (Wray et al., 2011). After 5 days, cells were stained
using an alkaline phosphatase kit (Sigma, 86 R-1KT) and colonies
counted.
For transcription factor induction of PGCLCs, the tri-cistronic
Ap2g-T2A-Prdm14-P2A-Blimp1 fragment (APB1, a kind gift
from Toshihiro Kobayashi and Azim Surani) was cloned into the
phCMV*1-cHA-IRES-H2BBFP plasmid. pPyCAG-PBase, pPBCAG-
rtTA-IN, and phCMV*1-APB-IRES-H2BBFP were co-transfected(C) Differentiation scheme for Nodal KO clones in inductive condition
(D) Aggregate morphology on day 4 of PGCLC induction. Scale bar, 1
(E) qRT-PCR assay for PGC-associated genes during PGCLC induction.
(F) Experimental setup for neural differentiation. Number of SOX1-po
(G) Activin A/GSK3(i) induction on WT and KO clones. Number of BR
Two independent Nodal KO clones from three independent experimen
pairwise comparison of WT and KO. See also Figure S5.
12 Stem Cell Reports j Vol. 9 j 1–15 j July 11, 2017into RGd2 cells by TransIT-LT1 followed by G418 selection
(400 mg/mL). For PGCLC induction, cells sorted at 24 hr for
RGd2 expression were plated at 2,500 cells per well in a 96-well
round-bottomed plate (Nakaki et al., 2013) in the presence or
absence of 1 mg/mL doxycycline (Sigma-Aldrich) in GK15 me-
dium (GMEM, 15% KSR [Sigma-Aldrich], 13 NEAA, 1 mM sodium
pyruvate, 1mML-glutamine, 0.1mM b-mercaptoethanol [Hayashi
et al., 2011]). For cytokine induction of PGCLCs, 2,500 cells
were plated in GK15 medium supplemented with 1,000 U/mL
LIF, 500 ng/mL bone morphogenetic protein 2 (R&D),
100 ng/mL stem cell factor (R&D), and 50 ng/mL EGF. Aggregates
were collected on days 2 and 4 for qRT-PCR.
To generate Nodal knockout clones, we transfected RGd2 cells
with Cas9 and the guide RNAs CCT CTG CTC CTG AGG CCG
GT and CAG TGG CTT GGT CTT CAC GG, which target exons 2
and 3, respectively. Single-cell-derived clones were picked after
55 hr of puromycin selection and a further 5 days of culture.
Knockout clones were identified by qRT-PCR and cultured in paral-
lel in either 2i or 2i supplemented with 5 ng/mL activin A (rescue).
For differentiation studies with rescue cultures, activin A was pre-
sent for the initial 24 hr until sorting.
Flow Cytometric Analysis of Fluorescent Reporters
Cells were dissociated into a single-cell suspension using Accutase
and resuspended in PBS + 5% fetal bovine serum for analysis using
an LSR Fortessa Analyzer (BD Biosciences).
Immunohistochemistry
Samples were fixed with 4% paraformaldehyde for 10 min at room
temperature, permeabilized, and blocked for 2 hr with block buffer
(PBS + 0.03% Triton X-100 + 3% donkey serum). Cells were
incubated overnight at 4C in block buffer with primary antibodies
(Table S1). After three washes with PBS + 0.03% Triton X-100, cells
were incubated with secondary antibodies (Life Technologies,
1:1,000) and DAPI in blocking buffer for 3 hr in the dark. After
three washes with PBS + 0.03% Triton X-100, cells were left
in PBS before imaging. Images were acquired using a Leica
DMI3000 B inverted microscope and fluorescence in single cells
quantified using CellProfiler (Jones et al., 2008). The number of
cells was normalized for each independent experiment (e.g., high-
est density for a given independent experiment = 1).
Immunostaining of Surface Markers for Flow
Cytometry
Cells were dissociated with enzyme-free Cell Dissociation Buffer
(Life Technologies, 13151-014) at 37C. Cells were resuspended
with staining buffer (PBS + 1% rat serum) and incubated with
directly conjugated antibodies (Table S1) for 30 min at 4C in thes for PGCLCs.
mm.
sitive cells is shown.
ACHYURY-positive cells is shown.
ts, mean and SD shown. *p < 0.01, **p < 0.001, ***p < 0.0001 in
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on an LSR Fortessa (BD Biosciences). Spherotech beads were used
to quantify the number of cells. Undifferentiated ESCs stained
with primary and secondary antibodies were used for FACS gating.
Gene Expression Analysis
RNA isolation from cell populations was performed with an
RNAeasy kit (Qiagen). SuperScriptIII (Invitrogen) and oligo(dT)
primers were used to synthesize cDNA. TaqMan, UPL, and
SybrGreen probes were used (Table S2).
Gene Knockdown
Qiagen FlexiTube siRNAs for Nodal, Tdgf1, Smad2, and Smad3 at a
final concentration of 20 nM were used for gene knockdown.
1.5 3 104 cells/cm2 were transfected in 24-well plates containing
500 mL of 2i medium with 0.5 mL of Lipofectamine RNAiMAX
(Life Technologies, 13778075). After overnight incubation, cells
were washed once with PBS before transfer to N2B27. Efficiency
of transfection was quantified by flow cytometry on RGd2 cells
transfected overnight with siRNA against GFP. Gene knockdown
was quantified by qRT-PCR after overnight transfection.
Immunoblotting
Western blotting was performed using standard techniques.
Primary antibodies (Table S1) were detected using peroxidase-con-
jugated secondary antibodies (Sigma-Aldrich, 1:5,000). Amersham
ECL western blotting detection reagent (RPN2106) was used ac-
cording to the manufacturer’s instructions.
Statistics
ANOVA was used to compare three or more samples. Two-tailed
Student’s t test was used for pairwise comparisons. For all experi-
ments, nR 3.
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Table S1 – Antibodies used in this study 
Antigen Supplier Cat. No Dilution 
SOX1 1:200 
OCT4 
4194 
sc-5279 or sc-8628 1:400 
NANOG 1:200 
KLF4 1:300 
Tuj1 1:500 
FOXA2 
14-5761-80 
ab72543 
MAB1195 
ab40874 1:200 
SOX17 AF1924 1:200 
BRACHYURY AF2085 1:200 
ESRRB PP-H6705-00 1:300 
mKO2 M168-3 1:1000 
BLIMP1 14-5963-82 1:50 
SMAD2 3101 1:1000 
p-SMAD2 3103 1:1000 
GAPDH G8795 1:5000 
E-CADHERIN 50-3249-82
CXCR4 552967 or 558644
FLK1
Cell Signalling 
Santa Cruz 
eBioscience 
Abcam 
R&D 
Abcam 
R&D 
R&D 
Perseus 
Amalgaam-MBL 
eBiosciences 
Cell Signalling 
Cell Signalling 
Sigma-Aldrich 
eBioscience 
BD Biosciences 
BD Biosciences 562941
Table S2 – Primers and probes used in this study 
 
 
Target Forward primer Reverse primer UPL probe 
Actb ggagattactgctctggctcc acagagtacttgcgctcaggagg - 
Gdf3 tgttcgtgggaacctgct ccatcttggaaaggtttctgtg - 
Lefty2 cacaagttggtccgtttcg ggtacctcggggtcacaat 78 
Nanos3 caaggcaaagacacaggatg cttcctgccacttttggaac 25 
Nodal ccaaccatgcctacatcca cacagcacgtggaaggaac 40 
Pou3f1 catttttcgtttcgttttaccc gagcgcagaccctctctg 72 
Pou3f3 tctgagaccgcccacaag gagcggcagtcagcaaag 22 
Prdm1 UTR ggtgaatcagggtgccttta gagaggtgcagggaagcac 109 
Prdm14 UTR aaaatgaccttgaattacaggattaag cataccaaatctctaggtagtgcaaa 76 
Smad2 taagaatgagttttgtgaagggc agcaaggagtacttgttactgtctg - 
Smad3 tccgtatgagcttcgtcaaagg tagctcaatccagcagggg - 
Stella tggaaattagaacgtacatactccaa gatgcacaacgatccagattt 73 
Tdgf1 gtttgaatttggacccgttg ggaaggcacaaactggaaag 93 
Tfap2c UTR aaaagaggaaggaaacaggaaag gggtcccctgtttttaagga 40 
Zic1 aacctcaagatccacaaaagga cctcgaactcgcacttgaa 7 
    
TaqMan probes   
Pou5f1    
Sox2    
Nanog    
Esrrb    
Zfp42    
Klf2    
Otx2    
Fgf5    
Pim2    
Sox1    
Dnmt3b 
Gapdh    
 
 
 
 SUPPLEMENTAL FIGURE LEGENDS 
Figure S1 – related to Figure 1 
(A) Flow cytometry histogram of RGd2 cells after removal of 2i. 
(B) Experimental set up for sorting experiments. 
(C) Flow cytometry profile of sorted fractions. 
(D) Replating capacity of 2i, 24hrs Rex1-high and 24hrs Rex1-low cells in 2i/LIF media.  
(E) Experimental set up for cytokine-dependent PGCLC induction and RT-qPCR of 
endogenous PGC-associated transcripts. *** p<0.0001, **p<0.001 in pairwise 
comparison of Rex1-high and Rex1-low. 
 
Figure S2 – related to Figure 2 
(A) Flow cytometry plots of RGd2+T::mKO2 cells in 2i, and Rex1-high sorted cells for 3 
days in control or ActivinA+GSK3(i). 
(B) Representative images of definitive endoderm differentiation immunostained for 
FOXA2 and SOX17. Scale bar= 50µm. 
(C) Quantification of the percentage of cells positive for SOX17 and FOXA2 during 
definitive endoderm differentiation.  
(D) Representative images of clonal definitive endoderm differentiation, showing an 
example of a clone predominantly SOX17 negative and a SOX17 positive clone.  
(E) Representative images of neural differentiation on day 2. Scale bar= 50µm. 
(F) Normalised number of cells during neural differentiation.  
(G) Immunostaining for SOX1 and Tuj1 of 2i, Rex1-high and Rex1-low cells after 6 and 
8 days of differentiation. Scale bar= 50µm. 
To determine the normalised number of cells as a percentage for each biological 
replicate, the number of cells was normalised by the highest value obtained in that 
biological replicate. 
*p<0.01 
 
Figure S3 – related to Figure 3 
(A) Western blot showing p-SMAD2, SMAD2 and GADPH protein in cells treated with 
control or Alk(i) for 30min. 
(B) Number of colonies of ES cells grown in 2i+DMSO or 2i+Alk(i) for three passages.  
(C) Representative images of NANOG and KLF4 immunostaining during the first 24hrs 
of differentiation (intensities have been enhanced for visualisation purposes). Scale 
bar= 20 µm. 
(D) RT-qPCR of Nodal, Tdgf1 and Smad2/3 siRNA treated cells after overnight 
transfection in 2i. siRNA knockdown did not affect the expression of pluripotency genes 
Pou5f1, Klf4 or Nanog but in some cases it did affect the expression of the NODAL 
signalling target Lefty2.  
(E) Quantification of the number of OCT4/SOX2 double positive cells, OCT4 
negative/SOX2 positive and SOX2/SOX1 double positive cells on day 3 of neural 
differentiation after treatment with siRNA.  
 * p <0.05,  ** p<0.01 
 
Figure S4 – related to Figures 4 and 5 
(A) Expression of NODAL pathway signalling components in 2i, Rex1-high and Rex1-
low cells (Kalkan et al. 2017). Fold changes are shown for genes showing a significant 
difference between 2i and Rex1-low cells (p<0.05). 
(B) NODAL inhibition before and during downregulation of Rex1 – Flow cytometry plot 
of RGd2 cells differentiated for 24hrs in Alk(i) or control (DMSO). 
(C) Relative expression of NODAL target genes, pluripotency and differentiation factors 
in Rex1-low cells arising from control or Alk(i) conditions by RT-qPCR. 2i and Rex1-high 
cells are included as controls.  
 (D) Percentage of T::mKO2 positive cells during ActivinA/GSK3(i) treatment of control 
or Alk(i) derived Rex1-low cells.  
(E) Lateral mesoderm differentiation of 24hrs Alk(i) or control treated Rex1-low cells. 
(F) Percentage of FLK1+/E-CADH- cells. 
(G) Number of clones after 4 days of definitive endoderm differentiation. 
To determine the normalised number of cells as a percentage for each biological 
replicate, the number of cells was normalised by the highest value obtained in that 
biological replicate.  
(H) Histogram showing the normalised number of cells. 
 (I) Experimental set up for cytokine-dependent PGCLC induction and RT-qPCR of 
endogenous PGC-associated transcripts of control or Alk(i)-treated cells.  
*p<0.05, **p<0.001, *** p<0.0001 in pairwise comparison of Rex1-high and Rex1-low. 
 
Figure S5 – related to figure 6 
(A) Strategy for inactivating Nodal  
(B) RT-qPCR for Pou5f1 (Oct4) and Nodal in picked clones. Clones 4 and 11 were 
negative for Nodal mRNA and were used for subsequent analysis 
 
